Cencora, Inc. (COR)
(Real Time Quote from BATS)
$239.79 USD
+0.03 (0.01%)
Updated Apr 26, 2024 10:55 AM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Cencora (COR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$248.07 | $275.00 | $213.00 | 3.47% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for Cencora comes to $248.07. The forecasts range from a low of $213.00 to a high of $275.00. The average price target represents an increase of 3.47% from the last closing price of $239.76.
Analyst Price Targets (14)
Broker Rating
Cencora currently has an average brokerage recommendation (ABR) of 1.53 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms. The current ABR compares to an ABR of 1.53 a month ago based on 15 recommendations.
Of the 15 recommendations deriving the current ABR, 11 are Strong Buy, representing 73.33% of all recommendations. A month ago, Strong Buy represented 73.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 11 | 11 | 11 | 11 | 10 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.53 | 1.53 | 1.53 | 1.53 | 1.57 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/4/2024 | Argus Research Corp. | David A Toung | Strong Buy | Strong Buy |
2/26/2024 | SVB Securities | Michael Cherny | Not Available | Strong Buy |
2/5/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Hold | Hold |
11/3/2023 | Robert W. Baird & Co. | Eric W Coldwell | Strong Buy | Strong Buy |
10/11/2023 | Evercore Partners | Elizabeth Anderson | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.53 |
ABR (Last week) | 1.53 |
# of Recs in ABR | 15 |
Average Target Price | $248.07 |
LT Growth Rate | 9.80% |
Industry | Medical Services |
Industry Rank by ABR | 89 of 252 |
Current Quarter EPS Est: | 3.65 |